Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced that it received notice of allowance of a patent from the US office of patents and trademarks for its DME drug Optina™. Ampio also received a notice of allowance of a similar patent from the Canadian Intellectual Property Office. These initial patents cover the North American territories and multiple additional patents for using Optina™ for the treatment of macular edema and diabetic retinopathy are pending worldwide.

According to Michael Macaluso, Ampio's CEO, "Optina™ is an ultra-low oral (capsule), not commercially available, dose of danazol for the treatment of DME. To our knowledge, no other oral drug to treat this condition exists and there is currently no drug approved by the FDA for this condition. The allowance of these patents in North America is an important step in the development and commercialization of this novel drug as they include multiple claims for the beneficial effects of ultra-low dose Optina™ on vascular hyperpermeability encountered in DME and other vascular leakage syndromes. These patents have an unusually long patent life that expires in 2030. In contrast, most drugs at this stage of development (just before a pivotal trial) have exhausted a large portion of their patent life. These patent claims provide especially strong protection because of the unexpected finding of efficacy only at the very low doses. Ampio is currently in discussions with potential partners to co-develop Optina™ for DME."

Dr. David Bar-Or, Chief Scientific Officer for Ampio, explained, "The mode of action of Optin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... WASHINGTON , March 27, 2015 ... - The biopharmaceutical industry comes out on top as ... in a new report  from ndp│analytics. According to ... and development (R&D) investment over the last decade, accounting ... 2000-2012. A Short Video on ...
(Date:3/27/2015)... 27, 2015 A new report from Kalorama Information ... – Chile , Colombia ... targets for IVD firms.  The healthcare research firm said that ... strategies for the Latin American continent with a population of ... supply operations. However, the country,s regional economic clout does not ...
(Date:3/27/2015)... CHINA AID, the ... Rehabilitation Medicine and Healthcare, second to none in ... held at Shanghai New International Expo Center on 22-24 ... Suggestions on Encouraging Private Capital to Participate in the ... issued by the Ministry of Civil Affairs of ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... SEATTLE, Feb. 3, 2011 Dendreon Corporation (Nasdaq: ... its previously announced public offering of 2.875% convertible senior ... closed on its overallotment option in full to purchase ...  The sale of the Notes, including the exercise of ...
... FOREST, Ill., Feb. 3, 2011 Hospira, Inc. (NYSE: ... injectable pharmaceuticals, today announced U.S. Food and Drug Administration ... of the oncology drug approved in the United States. ... had 2010 U.S. sales of more than $140 million. ...
Cached Medicine Technology:Dendreon Announces Exercise and Closing of Overallotment Option 2Hospira Announces FDA Approval of Topotecan Injection 2
(Date:3/28/2015)... MILAN (PRWEB) March 28, 2015 ... thought-leaders in the fields of osteoporosis, osteoarthritis and ... on Osteoporosis, it may be the first time ... educational research forum that the hot-button topic is ... Based on the well-accepted scientific principles of Wolff’s ...
(Date:3/28/2015)... FL (PRWEB) March 28, 2015 ... conditions coverage is made available to all visitors who ... effective immediately. All members are encouraged to purchase the ... to avoid lack of proper coverage for pre-existing medical ... from one or two medical conditions with serious consequences ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... La Mirada, CA (PRWEB) March 28, 2015 ... with ear, nose and throat disorders, are ... Tinnitus is a common issue which is characterized by ... ears. Affecting 1 in 5 people, tinnitus is a ... or disorder and while it is non-fatal, tinnitus can ...
Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... , NEW YORK, Sept. 3 As millions of ... classes every day. , , Teens are at a ... a crash, due largely to lack of experience. Many of those crashes ... (NRSF), a non-profit group that produces free driver education programs. , ...
... PHOENIX, Sept. 3 Maldonado Medical, a Durable ... in continuing its commitment to physicians, patients and the ... (AMA) and other physician associations from several states in ... is against the following health insurers: Aetna Inc., Cigna ...
... Arnhem, September 2009 The September issue of ... Association of Urology, features an article and a video ... Patel et al, showing that the periurethral suspension technique ... after robot-assisted laparoscopic radical prostatectomy (RALP). RALP is ...
... Cancer Institute (NCI) has renewed a $11.5 million Specialized ... and treatment of ovarian cancer, which supports multidisciplinary research ... Pennsylvania. First approved in 1999, this marks the ... "The SPORE program has always been a bold experiment ...
... CLEVELAND, Sept. 3 At a time when many families ... of prescription medications, supermarket retailer Giant Eagle, Inc. is making ... available for free every day at all of its 210 ... Thursday, September 3, with a 10:15 AM kickoff press event ...
... , NEW YORK, Sept. 3 ... its catalogue. , , Anti-aging Products ... http://www.reportlinker.com/p0120340/Anti-aging-Products-and-Services-The-Global-Market.html , , This Report: ... for anti-aging maintenance including health maintenance, beauty and physical fitness , ...
Cached Medicine News:Health News:Back to School Brings Risks to Young Drivers; Traffic Crashes Leading Cause of Teen Death, Says National Road Safety Foundation 2Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 2Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 3Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 4Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 2Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 3Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 4Health News:Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 2Health News:Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 3Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 2Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 3Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 4Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 5Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 6Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 7Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 8Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 9Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 10Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 11Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 12Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 13Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 14Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 15Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 16Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 17Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 18Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 19Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 20Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 21
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: